Suchergebnisse - "Petrylak, Daniel P"

PubPharm (359)

1

Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Milowsky, M. | O'Donnell, P. | Hoimes, C. | +20

2

Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy : TROPHY-U-01 Cohort 3

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Grivas, P. | Pouessel, D. | Park, C. | +17

3

A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer : enfortumab vedotin plus pembrolizumab

enthalten in: Future oncology (London, England) | 2024

von Hoimes, C. | Flaig, T. | Milowsky, M. | +12

4

Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301 : A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy

enthalten in: European urology | 2024

von Rosenberg, J. | Mamtani, R. | Sonpavde, G. | +28

5

Avelumab First-line Maintenance for Advanced Urothelial Carcinoma : Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance

enthalten in: European urology | 2024

von Sridhar, S. | Powles, T. | Climent Durán, M. | +17

6

Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Petrylak, D. | Eigl, B. | George, S. | +14

7

Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer

enthalten in: Cancer discovery | 2023

von Santasusagna, S. | Zhu, S. | Jawalagatti, V. | +22

8

Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314

enthalten in: European urology oncology | 2023

von Lu, Y. | Plets, M. | Morrison, G. | +13

9

Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von O'Donnell, P. | Milowsky, M. | Petrylak, D. | +22

CommentIn: J Clin Oncol. 2023 Sep 1;41(25):4084-4086. - PMID 37490639

10

The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer : A Post Hoc Analysis of ARCHES

enthalten in: European urology | 2023

von Armstrong, A. | Iguchi, T. | Azad, A. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]